UTILITY therapeutics
Altrincham, United Kingdom (UK) ยท Science and Engineering
This profile has not been verified by the business owner.
Information may be incomplete or outdated.
Overview
UTILITY therapeutics Ltd., a biotechnology company focused on the U.S. development and commercialization of two European-approved antibiotics for the treatment of urinary tract infections (UTI, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today.
Pivmecillinam is an oral prodrug of mecillinam that is being developed for uncomplicated UTI (uUTI), and it has a unique mechanism of action for infections caused by Gram-negative bacteria, including extended-spectrum beta-lactamases. Mecillinam, an intravenous (IV) formulation, is being developed as a first-line therapy for complicated UTI (cUTI) in the hospital setting.
Contact Details
info@utilitytherapeutics.com
Altrincham, United Kingdom (UK)
Founded
2017
Employees
2-10
Categories
Keywords
#Clinical Development
#Infectious Diseases
#Antibacterial Therapies
Companies teams usually look at after UTILITY therapeutics
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.